Buscar en RiuNet

Listar

Todo RiuNet

Mi cuenta

Acceder

Ayuda RiuNet

Admin. UPV

Listar por autor "Trillo Mata, José Luis"

Mostrando ítems 1-10 de 10

Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

Usó Talamantes, Ruth; Trillo Mata, José Luis; Guadalajara Olmeda, María Natividad; Sancho Mestre, Carla; Vivas Consuelo, David José Juan (Elsevier, 2012-11)

Risk adjustment models allow stratifying the population, considering chronic disease as a predictor of drug costs. In this paper, we analyze outpatient drug spending using Clinical Risk Groups (CRG) to obtain patient risk ...
Análisis y desarrollo de un modelo predictivo del gasto farmacéutico ambulatorio ajustado a morbilidad y riesgo clínico

Usó Talamantes, Ruth (Universitat Politècnica de València, 2015-10-19)

[EN] Introduction: Changes in population structure, including aging, have a significant impact on chronicity, comorbidity and polypharmacy. In the field of pharmaceutical services, problems with drugs and outpatient ...
Gestor informatizado de prestación farmacéutica: evaluación de la satisfacción social y modelización del gasto farmacéutico ajustado por las condiciones crónicas de los pacientes

Trillo Mata, José Luis (Universitat Politècnica de València, 2013-07-01)

El sistema de receta electrónica (RELE) implica la mejora de los procesos de prescripción y dispensación farmacoterapéutica, así como una potenciación de la coordinación de los profesionales de la salud. En la presente ...
Methods to control the pharmaceutical cost impact of chronic conditions in the elderly

Vivas Consuelo, David José Juan; Usó Talamantes, Ruth; Trillo Mata, José Luis; Mendez Valera, Pablo (Expert Reviews (formerly Future Drugs), 2015-06)

Multimorbidity is the main cause of polypharmacy in elderly people, with the consequent increment in cost and use of inappropriate medication. To control cost, specific strategies have been implemented in healthcare ...
Modeling pharmaceutical cost in primary health care according to chronic conditions

Trillo Mata, José Luis; Guadalajara Olmeda, María Natividad; Barrachina Martínez, Isabel; De la Poza, Elena (Elsevier, 2011-11)

Controlling pharmaceutical costs has been the subject of research and analysis in many studies in health economics which have shown that the chronic conditions of patients are an important factor. The present work models ...
Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

Romero; M.; Usó Talamantes, Ruth; Vivas Consuelo, David José Juan; De la Poza, Elena; Sancho Mestre, C.; Trillo Mata, José Luis; Barrachina Martínez, Isabel (Elsevier, 2013-11)

Metabolic agents have the highest expense (130 million Euros per year in the Valencian Community) among the top five therapeutic categories of drugs for adults aged 18 and over. Treatment of Diabetes Mellitus (DM) is the ...
Pharmaceutical Cost Management in an Ambulatory Setting Using a Risk Adjustment Tool

Vivas Consuelo, David José Juan; Usó Talamantes, Ruth; Guadalajara Olmeda, María Natividad; Trillo Mata, José Luis; Sancho Mestre, Carla; Buigues Pastor, Laia (BioMed Central, 2014-10-21)

Background Pharmaceutical expenditure is undergoing very high growth, and accounts for 30% of overall healthcare expenditure in Spain. In this paper we present a prediction model for primary health care pharmaceutical ...
Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups

Vivas Consuelo, David José Juan; Usó Talamantes, Ruth; Trillo Mata, José Luis; Caballer Tarazona, María; Barrachina Martínez, Isabel; Buigues Pastor, Laia (Elsevier, 2014-06)

Background: Risk adjustment instruments applied to existing electronic health records and administrative datasets may contribute to monitoring the correct prescribing of medicines. Objective: We aim to test the suitability ...
Predictability of pharmaceutical spending using Clinical Risk Groups in the Valencian Community, Valencia

Usó Talamantes, Ruth; Caballer Tarazona, María; Buigues Pastor, Laia; Trillo Mata, José Luis; Guadalajara Olmeda, María Natividad; Vivas Consuelo, David José Juan (Elsevier, 2011-11)

The Valencian Community, with 5,000,000 inhabitants, is implementing a system of pharmaceutical management to reduce costs. This system is based on classifying patients in groups using the case mix system, Clinical Risk ...
Sistema de prescripción y dispensación electrónica en la Agencia Valenciana de Salud

De la Poza, Elena; Barrachina Martínez, Isabel; Trillo Mata, José Luis; Usó Talamantes, Ruth (EPI SCP, 2011)

[ES] El sistema de prescripción y dispensación electrónica supone un avance en el uso de nuevas tecnologías en el Sistema Nacional de Salud. Implica la mejora de los procesos de prescripción y dispensación farmacoterapéutica ...